ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer. It offers a small molecule antagonist of the glucocorticoid receptor, which has been implicated in resistance to various treatment modalities, including chemotherapy, immunotherapy, and anti-hormonal therapy, and across multiple cancers.
|HQ||South San Francisco, CA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (23-Sept-2021)
Closing stock price (23-Sept-2021)
When was ORIC Pharmaceuticals founded?
ORIC Pharmaceuticals was founded in 2014.
Who are ORIC Pharmaceuticals key executives?
ORIC Pharmaceuticals's key executives are Jacob Chacko, Lori Friedman and Pratik Multani.
How many employees does ORIC Pharmaceuticals have?
ORIC Pharmaceuticals has 57 employees.
Who are ORIC Pharmaceuticals competitors?
Competitors of ORIC Pharmaceuticals include Takeda Pharmaceutical, Celnova and Janssen Pharmaceuticals.
Where is ORIC Pharmaceuticals headquarters?
ORIC Pharmaceuticals headquarters is located at 240 E Grand Ave, South San Francisco.
Where are ORIC Pharmaceuticals offices?
ORIC Pharmaceuticals has offices in South San Francisco and San Diego.
How many offices does ORIC Pharmaceuticals have?
ORIC Pharmaceuticals has 2 offices.
Receive alerts for 300+ data fields across thousands of companies